Melissa Baird - 24 Feb 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Soleil Boughton, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 19:55:01 UTC
Previous filing
17 Dec 2021
Next filing
16 Mar 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Award $0 +299,401 $0.000000 299,401 24 Feb 2022 Class A Common Stock 299,401 Direct F1
transaction HIMS Stock Option (right to buy) Award $0 +1,658,679 $0.000000 1,658,679 24 Feb 2022 Class A Common Stock 1,658,679 $5.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments over 4 years, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), beginning March 15, 2022, subject to the individual's continuous service with the Company.
F2 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.